COMMUNIQUÉS West-GlobeNewswire

Royalty Financing avec HCRx : GENFIT annonce l’approbation de la modification des modalités de ses OCEANEs 2025

10/03/2025 - 22:10

Approbation de toutes les résolutions par les porteurs d’OCEANEs 2025 Closing du Royalty Financing et réception de la première tranche de 130 millions d’euros attendus prochainement À la suite du closing du Royalty [...]

Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs

10/03/2025 - 22:10

All resolutions approved by bondholders Closing of Royalty Financing and receipt of first €130 million instalment expected shortly Upon closing of the Royalty Financing, GENFIT will implement the Repurchase of the 2025 [...]

LifeMD Reports Fourth Quarter 2024 Results

10/03/2025 - 22:30

Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60% Adjusted EBITDA increased 78% to $9.0 million Telehealth adjusted EBITDA increased 396% to $5.9 million Full-year cash [...]

Druid City Vital Care Recognized at Vital Care Infusion Services Annual Conference

10/03/2025 - 22:50

TUSCALOOSA, Ala., March 10, 2025 (GLOBE NEWSWIRE) -- Druid City Vital Care (“Druid City”) was recently recognized at the Vital Care Infusion Services annual conference in Orlando, FL. Three locations -- Tuscaloosa, AL, [...]

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

09/03/2025 - 01:00

LOS ANGELES, March 08, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based [...]

Drs. Jeffrey Lieberman, M.D. and David Sinclair, Ph.D. to Present ‘The New Frontier of Longevity Science: Living Well Beyond Your Years’ at SXSW 2025

07/03/2025 - 23:09

World-leading authorities explore the potential for extending human lifespan on Monday, March 10 at the JW Marriott Austin AUSTIN, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Renowned neuroscientist, psychiatrist, and [...]

Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market

07/03/2025 - 23:15

ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative [...]

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

07/03/2025 - 23:30

KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today the closing of its upsized [...]

Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

07/03/2025 - 23:30

TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced it will host a conference call and webcast [...]

ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND ANNOUNCES UPSIZE

08/03/2025 - 00:28

For Immediate Release – Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, March 07, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ [...]

Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis

08/03/2025 - 15:00

ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and systemic lupus Phase 2 OLE data of ESK-001 at 40 mg BID [...]

Communiqué de presse : Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD

08/03/2025 - 19:00

Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD Cinq fois plus d’adultes traités par Dupixent présentaient une rémission soutenue à la [...]

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

08/03/2025 - 19:00

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were [...]

Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

08/03/2025 - 19:00

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly reduced oral [...]

Curia annonce un refinancement stratégique visant à soutenir la poursuite de sa croissance

08/03/2025 - 19:54

ALBANY, New York, 08 mars 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), l’une des principales organisations de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui le refinancement de [...]

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

07/03/2025 - 14:00

DALLAS, March 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) ("Taysha" or the "Company"), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene [...]

Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting

07/03/2025 - 14:30

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of two to three times per year Equivalent potency to bimekizumab with similar [...]

Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025

07/03/2025 - 14:30

THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare [...]

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

07/03/2025 - 14:30

SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]